Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 29.00
-0.75 (-2.52%)
Oct 30, 2026, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.9 billion as of October 30, 2026. It is the 25,810th most valuable company in the world and the 1,396th biggest in Taiwan. Its market cap has decreased by 15.33% in one year.
Market Cap
2.90B
Enterprise Value
2.19B
Revenue
1.87B
Global Rank
Country Rank
#1,396 Taiwan
PE Ratio
15.34
ChartMarket Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.90B, an increase of 103.41%. That is a compound annual growth rate of 2.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 2.90B | -4.76% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 5.68B |
| Delta Asia International | 5.43B |
| WeLeader Biomedical | 3.26B |
| Applied BioCode | 2.93B |
| Bonraybio | 2.68B |
| A Plus Biotechnology | 2.52B |
| Wellell | 2.36B |
| Dynamic Medical Technologies | 2.16B |